Takayasu disease with depression responded to vortioxetine.
作者信息
Bhatia Manjeet S
机构信息
Department of Psychiatry, UCMS and GTB Hospital, Dilshad Garden, Delhi, India.
出版信息
Ind Psychiatry J. 2024 Jan-Jun;33(1):179-180. doi: 10.4103/ipj.ipj_225_22. Epub 2023 Mar 30.
Abstract
摘要
相似文献
1
Takayasu disease with depression responded to vortioxetine.伴有抑郁症的高安氏病对伏硫西汀有反应。
Ind Psychiatry J. 2024 Jan-Jun;33(1):179-180. doi: 10.4103/ipj.ipj_225_22. Epub 2023 Mar 30.
2
Vortioxetine for the treatment of depression.伏硫西汀用于治疗抑郁症。
Ann Pharmacother. 2014 Jun;48(6):758-65. doi: 10.1177/1060028014528305. Epub 2014 Mar 27.
3
A naturalistic, 24-week, open-label, add-on study of vortioxetine in bipolar depression.一项自然主义、24 周、开放性、附加研究维拉唑酮治疗双相抑郁。
Psychiatr Pol. 2022 Jun 30;56(3):509-522. doi: 10.12740/PP/OnlineFirst/132962.
4
Vortioxetine Treatment for Depression in Alzheimer's Disease: A Randomized, Double-blind, Placebo-controlled Study.伏硫西汀治疗阿尔茨海默病抑郁：一项随机、双盲、安慰剂对照研究。
Clin Psychopharmacol Neurosci. 2022 May 31;20(2):311-319. doi: 10.9758/cpn.2022.20.2.311.
5
Vortioxetine Treatment for Depression in Patients with Prodromal vs Mild Alzheimer's Disease: A Six-Month, Open-Label, Observational Study.伴有前驱期或轻度阿尔茨海默病的抑郁症患者的伏硫西汀治疗：一项为期 6 个月的开放性观察研究。
J Prev Alzheimers Dis. 2024;11(2):375-381. doi: 10.14283/jpad.2023.132.
6
Vortioxetine vs. Other Antidepressants in Patients with Major Depressive Episode With or Without Substance Use Disorder.文拉法辛与其他抗抑郁药治疗伴有或不伴有物质使用障碍的重性抑郁发作患者的比较
Curr Neuropharmacol. 2021;19(12):2296-2307. doi: 10.2174/1570159X19666210113150123.
7
Treatment of Depression with Vortioxetine and Second Generation Antipsychotics During the Period of Remission Formation in Schizophrenia (Interim Data Analysis).在精神分裂症缓解期形成阶段使用伏硫西汀和第二代抗精神病药物治疗抑郁症（中期数据分析）
Consort Psychiatr. 2023 Mar 31;4(1):18-36. doi: 10.17816/CP3728.
8
What role for ▼vortioxetine?伏硫西汀有什么作用？
Drug Ther Bull. 2016 Mar;54(3):30-3. doi: 10.1136/dtb.2016.3.0387.
9
Depression and cerebrovascular disease: could vortioxetine represent a valid treatment option?抑郁症与脑血管疾病：伏硫西汀能否成为一种有效的治疗选择？
Clin Pract Epidemiol Ment Health. 2015 Feb 27;11:144-9. doi: 10.2174/1745017901511010144. eCollection 2015.
10
[Vortioxetine in the treatment of major depression].[伏硫西汀治疗重度抑郁症]
Riv Psichiatr. 2016 Nov-Dec;51(6):215-230. doi: 10.1708/2596.26720.
本文引用的文献
1
Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update.伏硫西汀——慢性神经性疼痛治疗的新前沿：综述与更新
Ther Adv Psychopharmacol. 2021 Sep 3;11:20451253211034320. doi: 10.1177/20451253211034320. eCollection 2021.
2
The prevalence and impact of depression in primary systemic vasculitis: a systematic review and meta-analysis.原发性系统性血管炎中抑郁的患病率和影响：系统评价和荟萃分析。
Rheumatol Int. 2020 Aug;40(8):1215-1221. doi: 10.1007/s00296-020-04611-7. Epub 2020 Jun 4.
3
Vortioxetine reduces pain hypersensitivity and associated depression-like behavior in mice with oxaliplatin-induced neuropathy.文拉法辛减少奥沙利铂诱导神经病变小鼠的痛觉过敏和相关的抑郁样行为。
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Dec 20;103:109975. doi: 10.1016/j.pnpbp.2020.109975. Epub 2020 May 25.
4
Views on glucocorticoid therapy in rheumatology: the age of convergence.风湿病学中糖皮质激素治疗的观点：趋同的时代。
Nat Rev Rheumatol. 2020 Apr;16(4):239-246. doi: 10.1038/s41584-020-0370-z. Epub 2020 Feb 19.
5
EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis.EULAR/ERA-EDTA 关于抗中性粒细胞胞浆抗体相关性血管炎治疗的建议。
Ann Rheum Dis. 2016 Sep;75(9):1583-94. doi: 10.1136/annrheumdis-2016-209133. Epub 2016 Jun 23.
6
Impaired quality of life, disability and mental health in Takayasu's arteritis.多发性大动脉炎患者的生活质量受损、残疾和心理健康状况不良。
Rheumatology (Oxford). 2013 Oct;52(10):1898-904. doi: 10.1093/rheumatology/ket238. Epub 2013 Jul 19.
7
2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.2012年修订的国际 Chapel Hill 共识会议血管炎命名法
Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.
Zotero 插件